Acorda Therapeutics reported $39.24M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Acorda Therapeutics ACOR:US $ 39.24M 9.29M
Agios Pharmaceuticals AGIO:US $ 99.27M 2.91M
ALKERMES ALKS:US 305.13M 16.95M
Amgen AMGN:US $ 3.74B 804M
Anika Therapeutics ANIK:US $ 40.25M 4.7M
Aptinyx Inc APTX:US $ 19.38M 207K
Arrowhead Research ARWR:US $ 110.25M 19.49M
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Cara Therapeutics CARA:US $ 32.7M 1.64M
Clovis Oncology CLVS:US $ 84.61M 6.4M
Cytokinetics CYTK:US $ 81.7M 4.39M
Enanta Pharmaceuticals ENTA:US $ 52.56M 5.49M
Gilead Sciences GILD:US $ 6393M 89M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Insmed INSM:US $ 142.94M 12.26M
Ligand Pharmaceuticals LGND:US $ 53.5M 6.24M
Mannkind MNKD:US $ 33.25M 3.24M
Merck MRK:GR 4.03B 149M
Moderna Inc MRNA:US 1.84B 38M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Teva Pharmaceutical TEVA:IT 4.37B 352M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M